Skip to main content
Figure 4 | BMC Genomics

Figure 4

From: Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

Figure 4

GM-CSF clinical outcome evaluation. GM-CSF showed a significant (p < 0.05) poor outcome regarding metastasis formation in case of over-expression in the test dataset (A). The significance was lost in the validation dataset (B), probably because of lack of sufficient data. Significance in test dataset was maintained when considering only early stage tumors (C).

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us